AORT Artivion, Inc.
$25.08▲ +1.74%
Healthcare
Other
After hours
$25.08▲ +0.00%
Sep 11, 5:05 PM ET
Volume 547.9K
Avg Volume (10D) 552.6K
Key Metrics & Fundamentals
Market Cap
$1.22B
P/E Ratio
102.2
Div Yield
–%
52W Range
19.16 - 48.25
% vs 50 MA
-4.34%
% vs 200 MA
-24.76%
RSI-14
40.4
MACD Histogram
-0.3400
Beta (1Y vs SPY)
0.31
Free Cash Flow
-$12.01M
Gross Rev
$125.76M
Gross Profit
$80.52M
EBITDA
$2.30M
COGS
$45.24M
Operating Exp
$88.88M
Operating Income
-$8.36M
EBIT
-$8.36M
Pretax Income
-$11.70M
Net Income
-$13.51M
EPS (Diluted)
-0.28
Price & Volume History
Loading chart…
Recent News
3 Profitable Stocks We Approach with Caution
StockStory · Sep 11, 2026 10:59 PM
Artivion Insider Sold Shares Worth $286,656, According to a Recent SEC Filing
MT Newswires · Sep 11, 2026 9:31 PM
3 Reasons to Avoid AORT and 1 Stock to Buy Instead
StockStory · Sep 8, 2026 2:07 PM
3 Russell 2000 Stocks Walking a Fine Line
StockStory · Sep 4, 2026 2:38 PM
Artivion (AORT) Stock Looks Cheap On Cash Flow But Pricey On Sales
Simply Wall St. · Aug 27, 2026 11:13 PM
Artivion (AORT) Bounces As AMDS Launch Narrative Keeps Fair Value In Focus
Simply Wall St. · Aug 27, 2026 4:18 PM
1 High-Flying Stock to Own for Decades and 2 Facing Challenges
StockStory · Aug 25, 2026 7:50 AM
Artivion Insider Sold Shares Worth $2,026,850, According to a Recent SEC Filing
MT Newswires · Aug 20, 2026 6:37 PM
Why Artivion (AORT) Stock Is Trading Up Today
StockStory · Aug 19, 2026 9:42 PM
5 Revealing Analyst Questions From Artivion’s Q2 Earnings Call
StockStory · Aug 15, 2026 9:09 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See AORT's money flow as a full page
Social Sentiment
No Reddit posts found for AORT.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.